FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1043111000001104: Clarithromycin 500mg modified-release tablets 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21683701000001117 Clarithromycin 500mg modified-release tablets 14 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21683801000001114 Clarithromycin 500mg modified-release tablets 14 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clarithromycin 500mg modified-release tablets 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet Is pack of Clarithromycin 500mg m/r tablet false Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet Has active ingredient Clarithromycin false Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet Has VMP Clarithromycin 500mg m/r tablet false Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet Has specific active ingredient Clarithromycin true Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet Has VMP Clarithromycin 500mg modified-release tablets false Inferred relationship Existential restriction modifier
Clarithromycin 500mg modified-release tablets 14 tablet Has VMP Clarithromycin 500mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Klaricid XL 500mg tablets (Viatris UK Healthcare Ltd) 14 tablet Is a True Clarithromycin 500mg modified-release tablets 14 tablet Inferred relationship Existential restriction modifier
Clarie XL 500mg tablets (Teva UK Ltd) 14 tablet 2 x 7 tablets Is a True Clarithromycin 500mg modified-release tablets 14 tablet Inferred relationship Existential restriction modifier
Febzin XL 500mg tablets (Actavis UK Ltd) 14 tablet 2 x 7 tablets Is a True Clarithromycin 500mg modified-release tablets 14 tablet Inferred relationship Existential restriction modifier
Mycifor XL 500mg tablets (Forum Products Ltd) 14 tablet 2 x 7 tablets Is a True Clarithromycin 500mg modified-release tablets 14 tablet Inferred relationship Existential restriction modifier
Xetinin XL 500mg tablets (Morningside Healthcare Ltd) 14 tablet Is a True Clarithromycin 500mg modified-release tablets 14 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start